UCDC: Exploring Risk Factors in Asymptomatic Females with Ornithine Transcarbamylase Deficiency

26 de jun. de 2024 · 2m 5s

Descripción

New research from the Urea Cycle Disorders Consortium (UCDC). This summary is based on a paper published in the journal Molecular Genetics and Genomic Medicine on April 17, 2024, titled...

mostra más

New research from the Urea Cycle Disorders Consortium (UCDC). This summary is based on a paper published in the journal Molecular Genetics and Genomic Medicine on April 17, 2024, titled "Are asymptomatic carriers of OTC deficiency always asymptomatic? A multicentric retrospective study of risk using the UCDC longitudinal study database."

Read the paper here: https://onlinelibrary.wiley.com/doi/10.1002/mgg3.2443

Learn more about UCDC: https://ucdc.rarediseasesnetwork.org

Read more about this research from the National Urea Cycle Disorders Foundation: https://nucdf.org/news.html/article/2024/06/28/new-research-shows-female-otc-carriers-heterozygous-females-face-more-symptoms-risks-than-expected

mostra menos